Stocks To Buy: UBS bets on two Midcap IT shares for revenue recovery, growth prospects
UBS expects Mphasis' revenue to grow at a Compounded Annual Growth Rate (CAGR) of 10% over financial year 2025-2028, compared to a 2% CAGR from financial year 2022-2025.
UBS expects Mphasis' revenue to grow at a Compounded Annual Growth Rate (CAGR) of 10% over financial year 2025-2028, compared to a 2% CAGR from financial year 2022-2025.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
